Whom are we treating with adaptive servo-ventilation? - a clinical post-hoc analysis

M. Arzt (Regensburg, Germany)

Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Session: Obstructive and central sleep apnoea: consequences and comorbidities
Session type: Thematic Poster
Number: 2329
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Arzt (Regensburg, Germany). Whom are we treating with adaptive servo-ventilation? - a clinical post-hoc analysis. 2329

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Application of machine learning algorithms to predict loss of asthma control: A post-hoc analysis of INCONTRO study
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure: post hoc analysis of a randomised clinical trial
Source: ERJ Open Res, 7 (4) 00418-2021; 10.1183/23120541.00418-2021
Year: 2021



Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy
Source: International Congress 2017 – COPD management
Year: 2017


Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Are carbapenems a better antibiotic than others for treat ICU-AP? A post-hoc analysis of a prospective cohort.
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study
Source: ERJ Open Res, 5 (1) 00243-2018; 10.1183/23120541.00243-2018
Year: 2019



Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial
Source: Eur Respir J, 52 (2) 1800555; 10.1183/13993003.00555-2018
Year: 2018



Impact of grouping patients by 2017 GOLD strategy assessment criteria: a post hoc analysis of the TONADO and OTEMTO trials
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017


Improvements in lung function with umeclidinium/vilanterol analysed by reversibility at screening: a post hoc analysis of the EMAX trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


The impact of grouping patients by the 2017 GOLD COPD strategy on response to therapy: post hoc results from the TONADO tiotropium+olodaterol trials
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020


Validation of the codex index in patients with COPD enrolled in randomized clinical trials: A post-hoc analysis of the trilogy, trinity and tribute studies.
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020




Post-hoc analysis of the effect of montelukast in treating post-RSV-bronchiolitic respiratory symptoms in children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007


Symptom improvement over time with umeclidinium/vilanterol versus monotherapy: a post-hoc analysis of the EMAX trial
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Nintedanib in IPF: post hoc analysis of the Italian FIBRONET observational study
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


2-way remote monitoring in adaptive mode allows effective and realistic provision of home Non-Invasive Ventilation(NIV) to patients with severe COPD
Source: International Congress 2018 – New insights in the management of chronic respiratory failure
Year: 2018




Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017


Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial
Source: ERJ Open Res, 4 (4) 00136-2018; 10.1183/23120541.00136-2018
Year: 2018



Accuracy of objective tests for diagnosing adult asthma in symptomatic patients: A systematic literature review and hierarchical Bayesian latent-class meta-analysis.
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018


Comparative assessment of several automatic CPAP devices' responses: a bench test study
Source: ERJ Open Res 2015
Year: 2015